FDA Approves Xpert CT/NG Rapid Detection Test for Gonorrhea and Chlamydia To Enable Same Day Treatment Upon Diagnosis
Posted Dec 27 2012 9:36pm
Gonorrhea and Chlamydia with the use of the test and lab equipment from Cepheid can now have results in around 90 minutes. In addition the company has several other tests that function similarly with quick results.
This is pretty interesting to watch the video to see how the process works and the systems are stackable:) The modules uses cartridges and most tests take an hour. The systems also integrate with software and they use bar codes for identification.
In addition here’s how the cartridge works, very high tech molecular testing. BD
SUNNYVALE, Calif., Dec. 27, 2012 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced that it has received clearance from the U.S. Food & Drug Administration (FDA) to market Xpert® CT/NG. Running on Cepheid's GeneXpert® Systems, Xpert CT/NG is a qualitative in vitro molecular diagnostic test for the detection and differentiation of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG). For the first time, same-day patient consultation and treatment is possible for the two most common sexually transmitted bacterial infections in the United States.
"We are bringing to market a true next-generation molecular diagnostic product for detection of CT/NG — a test we designed from the ground up to provide accuracy, ease of use, and results availability," said John Bishop , Cepheid's Chief Executive Officer. "We expect this innovative diagnostic test to deliver new levels of confidence to clinicians, in addition to enabling same-day decisions about treating their patients — the critical first step in effectively managing these epidemics."